Selected research
Industry Research
Pet Genetic Defect Screening Platform Industry Research Report 2026
Market perspective
The global Pet Genetic Defect Screening Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pet Genetic Defect Screening Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pet Genetic Defect Screening Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pet Genetic Defect Screening Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pet Genetic Defect Screening Platform include Wisdom Panel, Embark Veterinary, Basepaws, Orivet Genetic Pet Care, Paw Print Genetics, Animal Genetics, VetGen, Antagene and Laboklin, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pet Genetic Defect Screening Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pet Genetic Defect Screening Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pet Genetic Defect Screening Platform Market by Company
Wisdom Panel
Embark Veterinary
Basepaws
Orivet Genetic Pet Care
Paw Print Genetics
Animal Genetics
VetGen
Antagene
Laboklin
UC Davis
OptiGen
VHLGenetics
Sinogene
PawKnows
Circle Dog
BGI Genomics
GENEWIZ
Pet Genetic Defect Screening Platform Segment by Type
Single Disease Gene Screening Platform
Whole Genome Multi-Disease Comprehensive Screening Platform
Pet Genetic Defect Screening Platform Segment by Application
Medical Institutions
Insurance Companies
Pet Breeding Companies
Others
Pet Genetic Defect Screening Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Genetic Defect Screening Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Genetic Defect Screening Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Genetic Defect Screening Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pet Genetic Defect Screening Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Disease Gene Screening Platform
- Whole Genome Multi-Disease Comprehensive Screening Platform
Applications
- Medical Institutions
- Insurance Companies
- Pet Breeding Companies
- Others
Companies covered
- Wisdom Panel
- Embark Veterinary
- Basepaws
- Orivet Genetic Pet Care
- Paw Print Genetics
- Animal Genetics
- VetGen
- Antagene
- Laboklin
- UC Davis
- OptiGen
- VHLGenetics
- Sinogene
- PawKnows
- Circle Dog
- BGI Genomics
- GENEWIZ
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pet Genetic Defect Screening Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single Disease Gene Screening Platform
- 2.2.3 Whole Genome Multi-Disease Comprehensive Screening Platform
- 2.3 Pet Genetic Defect Screening Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Institutions
- 2.3.3 Insurance Companies
- 2.3.4 Pet Breeding Companies
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Pet Genetic Defect Screening Platform Breakdown Data by Type
- 3.1 Global Pet Genetic Defect Screening Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Pet Genetic Defect Screening Platform Forecasted Market Size by Type (2027-2032)
4 Pet Genetic Defect Screening Platform Breakdown Data by Application
- 4.1 Global Pet Genetic Defect Screening Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Pet Genetic Defect Screening Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pet Genetic Defect Screening Platform Market Perspective (2021-2032)
- 5.2 Global Pet Genetic Defect Screening Platform Growth Trends by Region
- 5.2.1 Global Pet Genetic Defect Screening Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pet Genetic Defect Screening Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Pet Genetic Defect Screening Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Pet Genetic Defect Screening Platform Market Dynamics
- 5.3.1 Pet Genetic Defect Screening Platform Industry Trends
- 5.3.2 Pet Genetic Defect Screening Platform Market Drivers
- 5.3.3 Pet Genetic Defect Screening Platform Market Challenges
- 5.3.4 Pet Genetic Defect Screening Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pet Genetic Defect Screening Platform Players by Revenue
- 6.1.1 Global Top Pet Genetic Defect Screening Platform Players by Revenue (2021-2026)
- 6.1.2 Global Pet Genetic Defect Screening Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Pet Genetic Defect Screening Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pet Genetic Defect Screening Platform Head Office and Area Served
- 6.4 Global Pet Genetic Defect Screening Platform Players, Product Type & Application
- 6.5 Global Pet Genetic Defect Screening Platform Manufacturers Established Date
- 6.6 Global Pet Genetic Defect Screening Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pet Genetic Defect Screening Platform Market Size (2021-2032)
- 7.2 North America Pet Genetic Defect Screening Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pet Genetic Defect Screening Platform Market Size by Country (2021-2026)
- 7.4 North America Pet Genetic Defect Screening Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pet Genetic Defect Screening Platform Market Size (2021-2032)
- 8.2 Europe Pet Genetic Defect Screening Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pet Genetic Defect Screening Platform Market Size by Country (2021-2026)
- 8.4 Europe Pet Genetic Defect Screening Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pet Genetic Defect Screening Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Pet Genetic Defect Screening Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pet Genetic Defect Screening Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pet Genetic Defect Screening Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pet Genetic Defect Screening Platform Market Size (2021-2032)
- 10.2 South America Pet Genetic Defect Screening Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pet Genetic Defect Screening Platform Market Size by Country (2021-2026)
- 10.4 South America Pet Genetic Defect Screening Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pet Genetic Defect Screening Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Pet Genetic Defect Screening Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Wisdom Panel
- 12.1.1 Wisdom Panel Company Information
- 12.1.2 Wisdom Panel Business Overview
- 12.1.3 Wisdom Panel Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.1.4 Wisdom Panel Pet Genetic Defect Screening Platform Product Portfolio
- 12.1.5 Wisdom Panel Recent Developments
- 12.2 Embark Veterinary
- 12.2.1 Embark Veterinary Company Information
- 12.2.2 Embark Veterinary Business Overview
- 12.2.3 Embark Veterinary Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.2.4 Embark Veterinary Pet Genetic Defect Screening Platform Product Portfolio
- 12.2.5 Embark Veterinary Recent Developments
- 12.3 Basepaws
- 12.3.1 Basepaws Company Information
- 12.3.2 Basepaws Business Overview
- 12.3.3 Basepaws Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.3.4 Basepaws Pet Genetic Defect Screening Platform Product Portfolio
- 12.3.5 Basepaws Recent Developments
- 12.4 Orivet Genetic Pet Care
- 12.4.1 Orivet Genetic Pet Care Company Information
- 12.4.2 Orivet Genetic Pet Care Business Overview
- 12.4.3 Orivet Genetic Pet Care Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.4.4 Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Product Portfolio
- 12.4.5 Orivet Genetic Pet Care Recent Developments
- 12.5 Paw Print Genetics
- 12.5.1 Paw Print Genetics Company Information
- 12.5.2 Paw Print Genetics Business Overview
- 12.5.3 Paw Print Genetics Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.5.4 Paw Print Genetics Pet Genetic Defect Screening Platform Product Portfolio
- 12.5.5 Paw Print Genetics Recent Developments
- 12.6 Animal Genetics
- 12.6.1 Animal Genetics Company Information
- 12.6.2 Animal Genetics Business Overview
- 12.6.3 Animal Genetics Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.6.4 Animal Genetics Pet Genetic Defect Screening Platform Product Portfolio
- 12.6.5 Animal Genetics Recent Developments
- 12.7 VetGen
- 12.7.1 VetGen Company Information
- 12.7.2 VetGen Business Overview
- 12.7.3 VetGen Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.7.4 VetGen Pet Genetic Defect Screening Platform Product Portfolio
- 12.7.5 VetGen Recent Developments
- 12.8 Antagene
- 12.8.1 Antagene Company Information
- 12.8.2 Antagene Business Overview
- 12.8.3 Antagene Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.8.4 Antagene Pet Genetic Defect Screening Platform Product Portfolio
- 12.8.5 Antagene Recent Developments
- 12.9 Laboklin
- 12.9.1 Laboklin Company Information
- 12.9.2 Laboklin Business Overview
- 12.9.3 Laboklin Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.9.4 Laboklin Pet Genetic Defect Screening Platform Product Portfolio
- 12.9.5 Laboklin Recent Developments
- 12.10 UC Davis
- 12.10.1 UC Davis Company Information
- 12.10.2 UC Davis Business Overview
- 12.10.3 UC Davis Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.10.4 UC Davis Pet Genetic Defect Screening Platform Product Portfolio
- 12.10.5 UC Davis Recent Developments
- 12.11 OptiGen
- 12.11.1 OptiGen Company Information
- 12.11.2 OptiGen Business Overview
- 12.11.3 OptiGen Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.11.4 OptiGen Pet Genetic Defect Screening Platform Product Portfolio
- 12.11.5 OptiGen Recent Developments
- 12.12 VHLGenetics
- 12.12.1 VHLGenetics Company Information
- 12.12.2 VHLGenetics Business Overview
- 12.12.3 VHLGenetics Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.12.4 VHLGenetics Pet Genetic Defect Screening Platform Product Portfolio
- 12.12.5 VHLGenetics Recent Developments
- 12.13 Sinogene
- 12.13.1 Sinogene Company Information
- 12.13.2 Sinogene Business Overview
- 12.13.3 Sinogene Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.13.4 Sinogene Pet Genetic Defect Screening Platform Product Portfolio
- 12.13.5 Sinogene Recent Developments
- 12.14 PawKnows
- 12.14.1 PawKnows Company Information
- 12.14.2 PawKnows Business Overview
- 12.14.3 PawKnows Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.14.4 PawKnows Pet Genetic Defect Screening Platform Product Portfolio
- 12.14.5 PawKnows Recent Developments
- 12.15 Circle Dog
- 12.15.1 Circle Dog Company Information
- 12.15.2 Circle Dog Business Overview
- 12.15.3 Circle Dog Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.15.4 Circle Dog Pet Genetic Defect Screening Platform Product Portfolio
- 12.15.5 Circle Dog Recent Developments
- 12.16 BGI Genomics
- 12.16.1 BGI Genomics Company Information
- 12.16.2 BGI Genomics Business Overview
- 12.16.3 BGI Genomics Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.16.4 BGI Genomics Pet Genetic Defect Screening Platform Product Portfolio
- 12.16.5 BGI Genomics Recent Developments
- 12.17 GENEWIZ
- 12.17.1 GENEWIZ Company Information
- 12.17.2 GENEWIZ Business Overview
- 12.17.3 GENEWIZ Revenue in Pet Genetic Defect Screening Platform Business (2021-2026)
- 12.17.4 GENEWIZ Pet Genetic Defect Screening Platform Product Portfolio
- 12.17.5 GENEWIZ Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst